Abstract:Abstract Importance: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections outbreak in China is now a global issue. There is only a limited understanding of the clinical characteristics of patients with SARS-CoV-2 infections is available.Objective:To describe the characteristics, management strategies, and outcomes of critically ill patients with SARS-CoV-2 infection.Design, Setting, and Patients: This is aretrospective, multi-center case series of 50 critically ill patients with confirmed SARS-CoV-2 infection who were admitted at Zhongnan Hospital of Wuhan University and Wuhan Pulmonary Hospital in Wuhan, China, from January 8 to February 9, 2020.Exposures:Documented Corona Virus Disease, 2019 (COVID-19).Main Outcome Measures: Demographic, clinical, laboratory, imaging data were collected along with management strategies, complications and outcomes of enrolled individuals. Results Fifty critically ill patients with SARS-CoV-2 infections were enrolled. Their median age was 62 (range, 29-92) [IQR,49.5-69.0] years, 68% were male, and 28 (56%) patients had comorbidities, the most common being hypertension. In this cohort, 20(40%) patients survived ,16(32%) patients died, and the rest remained hospitalized. The invasive mechanical ventilator was used in 36(72%) patients with 15(30%) of them requiring prone positioning, and 17(34%) switched to ECMO. The compliance scores of lungs (Cstat)on the day of ICU admission among survivors were higher than those in non-survivors [42.0(18.0-47.0), vs. 19.5(14.0-24.2), p=0.038].The blood IL-6 levels and neutrophils counts at the first day of ICU admission were significantly higher in non-survivors compared to survivors [123.7(85.3-228.8), vs. 20.2(6.8-67.2) ng/ml, p=0.025 for IL-6, and 20.2(6.8-67.2) vs. 4.01(1.99-7.05) × 10⁹/L, p=0.02 for neutrophils counts].The heart rates, PaCO2, lung injury scale (LIS), and positive end-expiratory pressure levels were constantly higher for 10 days in non-survivors than those who survived (p<0.05). The frequency of vasopressor uses and neuromuscular blockers was higher in non-survivors from day 1 to day 10 compared to survivors (p<0.05). In the whole cohort, the most common complications were ARDS (97%), shock (44%), arrhythmia (38%), acute cardiac injury (26%), and acute kidney injury (22%). A secondary bacterial infection was noted in 17(34%) patients. Univariate analysis indicated that lower lung complianceand higher neutrophil counts at the day of ICU admission were related to higher mortality (p-0.03, and 0.04, respectively)ConclusionWe demonstrated that SARS-CoV-2 infection-related critical illness predominantly affected old individuals with comorbidities and characterized by severe hypoxemic respiratory failure, often requiring prolonged mechanical ventilation and rescue therapies. Low lung compliance and persistently elevated PaCO2 indicated poor outcomes.

Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19

The Mechanism of Multiple Organ Dysfunction Syndrome in Patients with COVID‐19

The mechanism of multiple organ dysfunction syndrome in patients with COVID-19

Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview

Non-pulmonary involvement in COVID-19: A systemic disease rather than a pure respiratory infection

Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations

Organ-specific manifestations of COVID-19 infection

Extrapulmonary Manifestations of SARS-CoV-2: A Report of 3 Cases and a Literature Review

COVID-19 Pulmonary and Extrapulmonary Complications

Eleven Faces of Coronavirus Disease 2019

Current epidemiological and clinical features of COVID-19; a global perspective from China.

Beyond the lung involvement in COVID-19 patients

A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations

ACE2, TMPRSS2 Distribution and Extrapulmonary Organ Injury in Patients with COVID-19.

Clinical features of critically ill patients with COVID-19 infection in China

Summary of the clinical manifestations, infection mechanisms and current drug treatment of SARS-CoV-2 infection

Imaging and Clinical Features of Patients with 2019 Novel Coronavirus SARS‐CoV‐2: A Systematic Review and Meta‐analysis

COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

Clinical Characteristics, Laboratory Abnormalities and CT Findings of COVID-19 Patients and Risk Factors of Severe Disease: a Systematic Review and Meta-Analysis.

Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia

Cardiovascular Manifestations in Severe and Critical Patients with COVID‐19